Access to precision cancer medicine in Norway

Policy dialogue facilitated by the European Observatory on Health Systems and Policies:

Increasing levels of precision in cancer treatment challenge the currentaccess pathways. As patient populations become smaller, the evidence becomes more limited, putting strain on traditional regulatory and reimbursement models.

The discussion will focus on how Norway can leverage outcomes from EU initiatives, cross-border trial evidence, and evolving access frameworks to overcome the structural barriers and ensure that advances in PCM translate into better and equitable care for cancer patients.

View the preliminary agenda here.

Please contact info@cancermission.no for further information on this event.